Dabigatran reversal with idarucizumab

Ryan P. Radecki; Thomas G. DeLoughery

doi:10.1056/NEJMc1711337

Dabigatran reversal with idarucizumab

Ryan P. Radecki, Thomas G. DeLoughery

Knight Cancer Institute

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1690-1691
Number of pages	2
Journal	New England Journal of Medicine
Volume	377
Issue number	17
DOIs	https://doi.org/10.1056/NEJMc1711337
State	Published - Oct 26 2017

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1711337

Cite this

@article{b9f8eae69c2a4477920a6e3a655d1a0f,

title = "Dabigatran reversal with idarucizumab",

author = "Radecki, {Ryan P.} and DeLoughery, {Thomas G.}",

year = "2017",

month = oct,

day = "26",

doi = "10.1056/NEJMc1711337",

language = "English (US)",

volume = "377",

pages = "1690--1691",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "17",

}

TY - JOUR

T1 - Dabigatran reversal with idarucizumab

AU - Radecki, Ryan P.

AU - DeLoughery, Thomas G.

PY - 2017/10/26

Y1 - 2017/10/26

UR - http://www.scopus.com/inward/record.url?scp=85032476086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032476086&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1711337

DO - 10.1056/NEJMc1711337

M3 - Letter

C2 - 29082733

AN - SCOPUS:85032476086

SN - 0028-4793

VL - 377

SP - 1690

EP - 1691

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 17

ER -

Dabigatran reversal with idarucizumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this